MTRI MEXC RealStocks
Own real MTRI shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Mentari Therapeutics, Inc. (MTRI)
NASDAQ
$18.88
-$0.14
(-0.74%)
After-Hours
Mentari Therapeutics, Inc. (MTRI) Live Price Chart
Last updated: 2026-11-13 22:24:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Mentari Therapeutics, Inc. (MTRI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $18.88, with a market capitalization of $1.07B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12.20 to $19.70. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.07B | |
$19.02 | |
$19.70 | |
$17.65 | |
$18.35 | |
11.86K | |
63.50K | |
-- | |
$19.70 | |
$12.20 | |
-- | |
-- |
Mentari Therapeutics, Inc. (MTRI) After-Hours Stock Price
Mentari Therapeutics, Inc. (MTRI) is trading at $18.45 in after-hours trading as of 2026-11-13 21:40:00, down 2.30% ($0.43) from the regular-session close of $18.88.
After-hours trading shows how investors are pricing MTRI after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Mentari Therapeutics, Inc. (MTRI) 7-Day Stock Price Change
Over the past seven days, Mentari Therapeutics, Inc. (MTRI) moved from $16.00 to $18.88, representing a gain of 18.00% ($2.88).
The stock traded between $12.20 and $19.70 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 63.50 thousand shares, -- versus the previous seven-day period, indicating -- trading activity.
MTRI 52-Week Price Position
Position in Range: 89.1%
52W Low$12.20
52W High$19.70
MTRI is currently trading at $18.88, placing it 89.1% of the way from its 52-week low of $12.20 to its 52-week high of $19.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Mentari Therapeutics, Inc. (MTRI)?
Mentari Therapeutics Inc is a biotechnology company engaged in the development of therapies for the prevention of migraine. Its product pipeline includes MT-001, an anti-PACAP monoclonal antibody, and MT-002, a bispecific antibody targeting both CGRP and PACAP pathways. The company's research and development activities focus on therapeutic candidates targeting PACAP and CGRP-related mechanisms for migraine prevention.
Mentari Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
| Company Website |
Ways to Trade MTRI at MEXC
How to Buy Mentari Therapeutics, Inc. (MTRI) Stock on MEXC
Eligible investors can buy real shares of Mentari Therapeutics, Inc. (MTRI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for MTRI and Place Your Order
Open the RealStocks trading page and search for MTRI. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.
Frequently Asked Questions (FAQ)
1.What is Mentari Therapeutics, Inc. (MTRI) stock price today?
Mentari Therapeutics, Inc. (MTRI) is currently trading at $18.88, down 0.74% ($0.14) from the previous close of $18.35. Intraday prices update in real time during regular trading hours.
2.Is MTRI stock going up or down today?
As of 2026-11-13 21:40:00, MTRI is trading at $18.88, down 0.74% ($0.14) from its previous close of $18.35. The stock has traded between $17.65 and $19.70 during today’s regular session. Past price movements do not guarantee future results.
3.What is MTRI pre-market price?
As of 2026-11-13 21:40:00, MTRI is trading at $18.50 in pre-market trading, up 0.82% ($0.15) from the previous close of $18.35. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is MTRI after-hours price?
As of 2026-11-13 21:40:00, MTRI is trading at $18.45 in after-hours trading, down 2.30% ($0.43) from the regular-session close of $18.88. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is MTRI stock trading now?
MTRI trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does MTRI sit relative to its 52-week high and low?
Over the past 52 weeks, MTRI has traded between a low of $12.20 and a high of $19.70. At $18.88, the stock is positioned 89.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Mentari Therapeutics, Inc. in?
Mentari Therapeutics, Inc. (MTRI) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Mentari Therapeutics, Inc.'s market capitalization and where is it listed?
Mentari Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $1.07B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is MTRI valued in terms of P/E ratio and EPS?
MTRI trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Mentari Therapeutics, Inc. pay a dividend?
Mentari Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.
Explore More US Stocks
Largest Market Cap
See US stocks with the highest market capitalization
Most Actively Traded
Discover today's most actively traded US stocks
Top Gainers
Browse today's leading gainers in the US stock market
Top 5 Cryptocurrencies
Explore the cryptocurrencies with the highest market capitalization
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MTRI, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
MTRI Stock Calculator
Estimate the value between MTRI shares and USD.
MTRI Shares to USD
MTRI SharesMTRI
USDUSD
1.00 MTRI shares = 18.88 USD
Calculations are estimates based on the latest available price and are for reference only.